← Leaderboards
Bette J Caan
Kaiser Foundation Research Institute
$23,657,335
Attributed
$41,004,730
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,004,730 · 13
By mechanism
R01$16,433,379 · 6
UM1$12,007,587 · 1
U01$10,164,511 · 3
OT2$1,705,380 · 1
N01$673,960 · 1
R13$19,913 · 1
Top collaborators
- Garnet L. Anderson15 shared
- Electra D. Paskett15 shared
- Jeffrey A Meyerhardt10 shared
- Justin C Brown5 shared
- Kathryn H. Schmitz5 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Carol P Somkin$3,026,449
- Barbara Sternfeld$4,196,318
- Mark Christopher Hornbrook$5,605,661
- Alyce Sophia Adams$8,051,712
- Marilyn L Kwan$12,106,221
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDiagnosisCohortCancer SurvivorFatty Acid Glycerol EstersOutcome ForecastRecurrenceWomanQuality Of LifeIncidenceRisk FactorsResponseCostBody CompositionPhenotypeBiological MarkersTumorCancer PatientResearch PersonnelAgingCaliforniaFollow-UpCancer SurvivorshipMalignant Breast Neoplasm
Grant awards (55)
CANCAN - Kaiser$858,321
OT2 · FY2025 · CA · contact PI
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$373,541
U01 · FY2025 · CA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$737,025
U01 · FY2024 · CA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$302,223
U01 · FY2024 · CA
CANCAN - Kaiser$2,254
OT2 · FY2024 · CA · contact PI
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$1,075,931
U01 · FY2023 · CA
CANCAN - Kaiser$459,366
OT2 · FY2023 · CA · contact PI
Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort$1,502,372
U01 · FY2022 · CA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer$1,184,061
U01 · FY2022 · CA
CANCAN - Kaiser$385,439
OT2 · FY2022 · CA · contact PI
Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort$1,554,022
U01 · FY2021 · CA
Resistance Training to Reduce Chemotoxicity in Colon Cancer$788,917
R01 · FY2021 · CA · contact PI
Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort$1
U01 · FY2021 · CA
Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort$1,567,792
U01 · FY2020 · CA
Resistance Training to Reduce Chemotoxicity in Colon Cancer$790,915
R01 · FY2020 · CA · contact PI
Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort$1,584,592
U01 · FY2019 · CA
Resistance Training to Reduce Chemotoxicity in Colon Cancer$818,198
R01 · FY2019 · CA · contact PI
Cancer and Body Composition Webinar Series$19,913
R13 · FY2019 · CA · contact PI
Resistance Training to Reduce Chemotoxicity in Colon Cancer$863,821
R01 · FY2018 · CA · contact PI
Women's Health Initiative Cancer Survivor Cohort$175,562
UM1 · FY2018 · CA
Women's Health Initiative Cancer Survivor Cohort$2,260,718
UM1 · FY2017 · CA
Resistance Training to Reduce Chemotoxicity in Colon Cancer$870,094
R01 · FY2017 · CA · contact PI
(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival$607,944
R01 · FY2017 · CA · contact PI
Body Composition, Weight, and Colon Cancer Survival$582,515
R01 · FY2017 · CA · contact PI
Women's Health Initiative Cancer Survivor Cohort$165,708
UM1 · FY2017 · CA
Women's Health Initiative Cancer Survivor Cohort$56,922
UM1 · FY2017 · CA
Women's Health Initiative Cancer Survivor Cohort$2,396,733
UM1 · FY2016 · CA
(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival$602,462
R01 · FY2016 · CA · contact PI
Body Composition, Weight, and Colon Cancer Survival$600,053
R01 · FY2016 · CA · contact PI
Women's Health Initiative Cancer Survivor Cohort$170,764
UM1 · FY2016 · CA
Women's Health Initiative Cancer Survivor Cohort$2,539,856
UM1 · FY2015 · CA
Body Composition, Weight, and Colon Cancer Survival$691,472
R01 · FY2015 · CA · contact PI
(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival$630,131
R01 · FY2015 · CA · contact PI
Obesity and mortality after breast cancer diagnosis by race/ethnicity in the WHI Clinical Trial and Observational Cohorts$113,842
UM1 · FY2015 · CA
Women's Health Initiative Cancer Survivor Cohort$2,232,714
UM1 · FY2014 · CA
(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival$629,652
R01 · FY2014 · CA · contact PI
Body Composition, Weight, and Colon Cancer Survival$596,795
R01 · FY2014 · CA · contact PI
Women's Health Initiative Cancer Survivor Cohort$1,894,768
UM1 · FY2013 · CA
Molecular Profiles and Lifestyle Factors in Breast Cancer Prognosis$634,109
R01 · FY2013 · CA · contact PI
Body Composition, Weight, and Colon Cancer Survival$627,548
R01 · FY2013 · CA · contact PI
Molecular Profiles and Lifestyle Factors in Breast Cancer Prognosis$730,605
R01 · FY2012 · CA · contact PI
MSI-FLASH: An Exercise Intervention for Women with Menopausal Symptoms$282,951
U01 · FY2012 · AG · contact PI
Molecular Profiles and Lifestyle Factors in Breast Cancer Prognosis$739,594
R01 · FY2011 · CA · contact PI
Molecular Profiles and Lifestyle Factors in Breast Cancer Prognosis$765,561
R01 · FY2010 · CA · contact PI
Molecular Profiles and Lifestyle Factors in Breast Cancer Prognosis$749,195
R01 · FY2009 · CA · contact PI
Long Term Health Outcomes in Breast Cancer Survivors$500,819
R01 · FY2007 · CA · contact PI
Long Term Health Outcomes in Breast Cancer Survivors$535,523
R01 · FY2006 · CA · contact PI
Long Term Health Outcomes in Breast Cancer Survivors$530,273
R01 · FY2005 · CA
Long Term Health Outcomes in Breast Cancer Survivors$550,437
R01 · FY2004 · CA
BEHAVIORAL CORRELATES OF RECURRENCE IN BREAST CANCER$319,636
R01 · FY2003 · CA
BEHAVIORAL CORRELATES OF RECURRENCE IN BREAST CANCER$231,128
R01 · FY2002 · CA
BEHAVIORAL CORRELATES OF RECURRENCE IN BREAST CANCER$226,724
R01 · FY2001 · CA
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI$349,863
N01 · FY2000 · WH
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHI$324,097
N01 · FY2000 · WH
BEHAVIORAL CORRELATES OF RECURRENCE IN BREAST CANCER$219,258
R01 · FY2000 · CA